Identification of drug modulators targeting gene-dosage disease CMT1A

ACS Chemical Biology

Volumn 7, Issue 7, 2012, Pages 1205-1213

  Jang, Sung Wook ^a   Lopez Anido, Camila ^c   MacArthur, Ryan ^a   Svaren, John ^c   Inglese, James ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BORTEZOMIB; CLOFARABINE; FENRETINIDE; FIREFLY LUCIFERASE; MESSENGER RNA; NORDIHYDROGUAIARETIC ACID; OLVANIL; PERIPHERAL MYELIN PROTEIN 22; PODOPHYLLOTOXIN;

ARTICLE; DRUG IDENTIFICATION; DRUG TARGETING; GENE DOSAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CAPSAICIN; CHARCOT-MARIE-TOOTH DISEASE; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FENRETINIDE; GENE DOSAGE; GENE TARGETING; HUMANS; MYELIN PROTEINS;

EID: 84864129115     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300048d     Document Type: Article

References (44)

1. Garbay, B., Heape, A. M., Sargueil, F., and Cassagne, C. (2000) Myelin synthesis in the peripheral nervous system Prog. Neurobiol. 61, 267-304
2. Reilly, M. M., Murphy, S. M., and Laura, M. (2011) Charcot-Marie-Tooth disease J. Peripher. Nerv. Syst. 16, 1-14
3. Robertson, A. M., Perea, J., McGuigan, A., King, R. H., Muddle, J. R., Gabreels-Festen, A. A., Thomas, P. K., and Huxley, C. (2002) Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A J. Anat. 200, 377-390
4. Chance, P. F., Alderson, M. K., Leppig, K. A., Lensch, M. W., Matsunami, N., Smith, B., Swanson, P. D., Odelberg, S. J., Disteche, C. M., and Bird, T. D. (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies Cell 72, 143-151
5. Orfali, W., Nicholson, R. N., Guiot, M. C., Peterson, A. C., and Snipes, G. J. (2005) An 8.5-kb segment of the PMP22 promoter responds to loss of axon signals during Wallerian degeneration, but does not respond to specific axonal signals during nerve regeneration J. Neurosci. Res. 80, 37-46
6. Jones, E. A., Lopez-Anido, C., Srinivasan, R., Krueger, C., Chang, L. W., Nagarajan, R., and Svaren, J. (2011) Regulation of the PMP22 gene through an intronic enhancer J. Neurosci. 31, 4242-4250
7. Passage, E., Norreel, J. C., Noack-Fraissignes, P., Sanguedolce, V., Pizant, J., Thirion, X., Robaglia-Schlupp, A., Pellissier, J. F., and Fontes, M. (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease Nat. Med. 10, 396-401
8. Kaya, F., Belin, S., Bourgeois, P., Micaleff, J., Blin, O., and Fontes, M. (2007) Ascorbic acid inhibits PMP22 expression by reducing cAMP levels Neuromuscular Disord. 17, 248-253
9. Pareyson, D., Reilly, M. M., Schenone, A., Fabrizi, G. M., Cavallaro, T., Santoro, L., Vita, G., Quattrone, A., Padua, L., Gemignani, F., Visioli, F., Laura, M., Radice, D., Calabrese, D., Hughes, R. A., and Solari, A. (2011) Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial Lancet Neurol. 10, 320-328
10. Sereda, M. W., Meyer zu Horste, G., Suter, U., Uzma, N., and Nave, K. A. (2003) Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) Nat. Med. 9, 1533-1537
11. Hai, M., Muja, N., DeVries, G. H., Quarles, R. H., and Patel, P. I. (2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies J. Neurosci. Res. 69, 497-508
12. Zlokarnik, G. (2000) Fusions to beta-lactamase as a reporter for gene expression in live mammalian cells Methods Enzymol. 326, 221-244
13. Crouch, S. P., Kozlowski, R., Slater, K. J., and Fletcher, J. (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity J. Immunol. Methods 160, 81-88
14. Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A., Yasgar, A., Zheng, W., and Austin, C. P. (2006) Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries Proc. Natl. Acad. Sci. U.S.A. 103, 11473-11478
15. Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D. T., and Austin, C. P. (2011) The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics Sci. Transl. Med. 3, 80ps16
16. Auld, D. S., Lovell, S., Thorne, N., Lea, W. A., Maloney, D. J., Shen, M., Rai, G., Battaile, K. P., Thomas, C. J., Simeonov, A., Hanzlik, R. P., and Inglese, J. (2010) Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124 Proc. Natl. Acad. Sci. U.S.A. 107, 4878-4883
17. Reading, C. and Cole, M. (1977) Clavulanic acid: a beta-lactamase- inhiting beta-lactam from Streptomyces clavuligerus Antimicrob. Agents Chemother. 11, 852-857
18. Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screening 4, 67-73
19. Eastwood, B. J., Farmen, M. W., Iversen, P. W., Craft, T. J., Smallwood, J. K., Garbison, K. E., Delapp, N. W., and Smith, G. F. (2006) The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies J. Biomol. Screening 11, 253-261
20. Thorne, N., Auld, D. S., and Inglese, J. (2010) Apparent activity in high-throughput screening: origins of compound-dependent assay interference Curr. Opin. Chem. Biol. 14, 315-324
21. Auld, D. S., Thorne, N., Nguyen, D. T., and Inglese, J. (2008) A specific mechanism for nonspecific activation in reporter-gene assays ACS Chem. Biol. 3, 463-470
22. Wang, Y., Kubota, H., Yamada, N., Irie, T., and Akiyama, H. (2011) Quantum yields and quantitative spectra of firefly bioluminescence with various bivalent metal ions Photochem. Photobiol. 87, 846-852
23. Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., and Auld, D. S. (2007) High-throughput screening assays for the identification of chemical probes Nat. Chem. Biol. 3, 466-479
24. Suter, U., Snipes, G. J., Schoener-Scott, R., Welcher, A. A., Pareek, S., Lupski, J. R., Murphy, R. A., Shooter, E. M., and Patel, P. I. (1994) Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters J. Biol. Chem. 269, 25795-25808
25. Fortun, J., Go, J. C., Li, J., Amici, S. A., Dunn, W. A., Jr., and Notterpek, L. (2006) Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression Neurobiol. Dis. 22, 153-164
26. Notterpek, L., Ryan, M. C., Tobler, A. R., and Shooter, E. M. (1999) PMP22 accumulation in aggresomes: implications for CMT1A pathology Neurobiol. Dis. 6, 450-460
27. Newbern, J. and Birchmeier, C. (2010) Nrg1/ErbB signaling networks in Schwann cell development and myelination Semin. Cell Dev. Biol. 21, 922-928
28. Topilko, P., Schneider-Maunoury, S., Levi, G., Baron-Van Evercooren, A., Chennoufi, A. B., Seitanidou, T., Babinet, C., and Charnay, P. (1994) Krox-20 controls myelination in the peripheral nervous system Nature 371, 796-799
29. Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave, K. A., Birchmeier, C., and Wegner, M. (2001) The transcription factor Sox10 is a key regulator of peripheral glial development Genes Dev. 15, 66-78
30. Prasad, M. K., Reed, X., Gorkin, D. U., Cronin, J. C., McAdow, A. R., Chain, K., Hodonsky, C. J., Jones, E. A., Svaren, J., Antonellis, A., Johnson, S. L., Loftus, S. K., Pavan, W. J., and McCallion, A. S. (2011) SOX10 directly modulates ERBB3 transcription via an intronic neural crest enhancer BMC Dev. Biol. 11, 40
31. Le, N., Nagarajan, R., Wang, J. Y., Araki, T., Schmidt, R. E., and Milbrandt, J. (2005) Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination Proc. Natl. Acad. Sci. U.S.A. 102, 2596-2601
32. Parkinson, D. B., Bhaskaran, A., Arthur-Farraj, P., Noon, L., Woodhoo, A., Lloyd, A. C., Feltri, M. L., Wrabetz, L., Behrens, A., Mirsky, R., and Jessen, K. R. (2008) c-Jun is a negative regulator of myelination J. Cell Biol. 181, 625-637
33. Raivich, G. and Behrens, A. (2006) Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain Prog. Neurobiol. 78, 347-363
34. Maier, M., Berger, P., Nave, K. A., and Suter, U. (2002) Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves Mol. Cell. Neurosci. 20, 93-109
35. Verrier, J. D., Lau, P., Hudson, L., Murashov, A. K., Renne, R., and Notterpek, L. (2009) Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a Glia 57, 1265-1279
36. Bosse, F., Brodbeck, J., and Muller, H. W. (1999) Post-transcriptional regulation of the peripheral myelin protein gene PMP22/gas3 J. Neurosci. Res. 55, 164-177
37. Shin, Y. K., Jang, S. Y., Lee, H. K., Jung, J., Suh, D. J., Seo, S. Y., and Park, H. T. (2010) Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy Glia 58, 1961-1976
38. Latasa, M. J., Ituero, M., Moran-Gonzalez, A., Aranda, A., and Cosgaya, J. M. (2010) Retinoic acid regulates myelin formation in the peripheral nervous system Glia 58, 1451-1464
39. Sheikh, M. S., Shao, Z. M., Li, X. S., Ordonez, J. V., Conley, B. A., Wu, S., Dawson, M. I., Han, Q. X., Chao, W. R., Quick, T., Niles, R. M., and Fontana, J. A. (1995) N-(4-Hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma Carcinogenesis 16, 2477-2486
40. Dray, A. (1992) Neuropharmacological mechanisms of capsaicin and related substances Biochem. Pharmacol. 44, 611-615
41. Nobbio, L., Sturla, L., Fiorese, F., Usai, C., Basile, G., Moreschi, I., Benvenuto, F., Zocchi, E., De Flora, A., Schenone, A., and Bruzzone, S. (2009) P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy J. Biol. Chem. 284, 23146-23158
42. Landoure, G., Zdebik, A. A., Martinez, T. L., Burnett, B. G., Stanescu, H. C., Inada, H., Shi, Y., Taye, A. A., Kong, L., Munns, C. H., Choo, S. S., Phelps, C. B., Paudel, R., Houlden, H., Ludlow, C. L., Caterina, M. J., Gaudet, R., Kleta, R., Fischbeck, K. H., and Sumner, C. J. (2010) Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C Nat. Genet. 42, 170-174
43. Fanciulli, M., Petretto, E., and Aitman, T. J. (2009) Gene copy number variation and common human disease Clin. Genet. 77, 201-213
44. Conrad, B. and Antonarakis, S. E. (2007) Gene duplication: a drive for phenotypic diversity and cause of human disease Annu. Rev. Genomics Hum. Genet. 8, 17-35